Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

4.90
+0.13002.73%
Post-market: 4.86-0.0400-0.82%19:30 EDT
Volume:705.66K
Turnover:3.44M
Market Cap:202.84M
PE:-4.30
High:4.99
Open:4.80
Low:4.67
Close:4.77
52wk High:13.22
52wk Low:4.48
Shares:41.40M
Float Shares:33.77M
Volume Ratio:0.74
T/O Rate:2.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1385
EPS(LYR):-0.9533
ROE:-17.35%
ROA:-10.41%
PB:0.77
PE(LYR):-5.14

Loading ...

Rxsight Inc Q2 EPS USD -0.29

THOMSON REUTERS
·
Aug 06

RxSight, Inc. Expected to Post a Loss of 33 Cents a Share - Earnings Preview

Reuters
·
Aug 04

RxSight Coverage Assumed by UBS at Neutral

Dow Jones
·
Jul 29

UBS Adjusts Price Target on RxSight to $5.50 From $9, Maintains Neutral Rating

MT Newswires Live
·
Jul 28

Rxsight Grants New CEO Aziz Mottiwala Stock Options for 571,286 Shares at $5.19 Each

Reuters
·
Jul 27

Rxsight Reports Inducement Grants as Permitted by the NASDAQ Listing Rules

THOMSON REUTERS
·
Jul 27

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

GlobeNewswire
·
Jul 27

Rxsight CEO Aziz Mottiwala Files Initial Beneficial Ownership Statement

Reuters
·
Jul 25

RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed

TIPRANKS
·
Jul 16

Rxsight Names Aziz Mottiwala CEO, Ron Kurtz to Become Chief Medical Officer

Reuters
·
Jul 16

Rxsight Inc: not Updating Previously Communicated Financial Guidance in Connection with This Announcement

THOMSON REUTERS
·
Jul 16

Rxsight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.d. as Chief Medical Officer

THOMSON REUTERS
·
Jul 16

Rxsight - Ron Kurtz, M.d. to Resign from Board; Aziz Mottiwala to Join Board

THOMSON REUTERS
·
Jul 16

RxSight reports preliminary Q2 revenue $32M-$34M, consensus $32.07M

TIPRANKS
·
Jul 08

RxSight raises FY26 revenue view to $140M-$160M from $120M-$135M

TIPRANKS
·
Jul 08

RxSight price target lowered to $6.50 from $7.50 at Jefferies

TIPRANKS
·
Jul 08

Rxsight Price Target Maintained with a $11.00/share by Needham

Dow Jones
·
Jul 07

Analysts’ Top Healthcare Picks: Idexx Laboratories (IDXX), RxSight (RXST)

TIPRANKS
·
Jul 07

Swiss Stocks - Factors to Watch on July 7

Reuters
·
Jul 07

RxSight, Alcon Partner on Light-Adjustable Cataract Lenses

TIPRANKS
·
Jul 07